KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Operating Expenses (2016 - 2025)

Merck (MRK) has disclosed Operating Expenses for 17 consecutive years, with $13.0 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 13.32% to $13.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.9 billion through Dec 2025, down 0.65% year-over-year, with the annual reading at $43.9 billion for FY2025, 0.65% down from the prior year.
  • Operating Expenses for Q4 2025 was $13.0 billion at Merck, up from $10.5 billion in the prior quarter.
  • The five-year high for Operating Expenses was $20.4 billion in Q2 2023, with the low at $7.6 billion in Q1 2021.
  • Average Operating Expenses over 5 years is $11.2 billion, with a median of $10.4 billion recorded in 2023.
  • The sharpest move saw Operating Expenses soared 101.56% in 2023, then crashed 50.39% in 2024.
  • Over 5 years, Operating Expenses stood at $9.6 billion in 2021, then rose by 7.33% to $10.3 billion in 2022, then soared by 61.64% to $16.7 billion in 2023, then plummeted by 31.31% to $11.5 billion in 2024, then grew by 13.32% to $13.0 billion in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $13.0 billion, $10.5 billion, and $10.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.